(Date:11/6/2009)...ING VALLEY, Calif., Nov. 6 Calbiot... a Small Business Innovative Research (SBIR) Phase...Material command. Under terms of the agreement, Ca...SRs) for the diagnosis of Dengue virus. ,, D...resents a major threat to military forces deployed...
(Date:11/5/2009)...THERSBURG, Md., Nov. 5 G...inancial results for the third quarter ended Septe...million ($0.04 per share) for the three months end....8 million ($0.08 per share) in the comparable qua...30, 2009, GenVec,s net loss was $14.1 million ($0....
(Date:11/5/2009)...ference Call on Thursday, November 5, 2009 at 4:30...R Nov. 5 /PRNewswire-FirstCall/ - OncoGenex Pharma...SDAQ: OGXI ) today reported unaudited financial r... September 30, 2009 and reviewed the Company,s hig...ollowing consolidated results reflect the operatio...
(Date:11/5/2009)... DIEGO, CA, November 5, 2009 /PRNewswire-FirstCall...used on using proprietary taste receptor-based tec... the food, beverage, and ingredient supply industr...d financial results for the third quarter ended Se...the third quarter of 2009, compared to $4.0 millio...
Breaking Biology Technology:Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14...linary team of Cornell nanotechnology researchers ... material that holds promise for light-emitting, f...lved years of perfecting a technique for building ...ted in the Sept. 30 online publication of the jour...m had long studied the molecular semiconductor rut...
...ct. 9 Thermo Fisher,Scientific Inc. (NYSE: TMO )...nced it has acquired NanoDrop Technologies, LLC, a...visible (UV-Vis) instrumentation.,The acquisition ...s,spectrophotometry instruments for applications i...volume samples are used in emerging life,sciences ...
..., Oct. 9 Pharmaceutical and biotech,companies rea... they ensure,strong partnerships between R&D and m...mmercial focus in all stages of product developmen...that have traditionally,separated R&D from marketi...nted medical researchers and skillful marketers. ...
Other Biology Technology:CU researchers shed light on light-emitting nanodevice 2Thermo Fisher Scientific Acquires Leader in Micro-Volume Spectrophotometers, NanoDrop Technologies 2Thermo Fisher Scientific Acquires Leader in Micro-Volume Spectrophotometers, NanoDrop Technologies 3Pharmaceutical Product Launch: Commercially Focused R&D Increases Drug's Market Potential 2...lar biophysics and biochemistry at Yale has recei...dation to expand research on the delivery of a tar...les. , Garen and his collaborator Zhiwei Hu hav...he blood vessels of solid tumors, thus destroying ... , The technology uses a synthetic gene encoding...
... with a drug compound substantially improved learn..., say researchers at the Stanford University Schoo...al. What’s more, the gains lasted for months after...re now considering a clinical trial to test whethe... Down syndrome. , "This treatment has remarkable p...
...uld help control weight, lower fat and cholesterol...ports Lisa Richards in Chemistry & Industry, t...been hailed for its cholesterol lowering capabilit...nufacturer Birds Eye has added the beans to its ra...wn that black soya may be even more potent in rats...
Other Biology News:Nanoparticles for delivery of prostate cancer treatment 2Drug treatment improves learning in mice with Down syndrome symptoms, Stanford/Packard study shows 2Drug treatment improves learning in mice with Down syndrome symptoms, Stanford/Packard study shows 3Drug treatment improves learning in mice with Down syndrome symptoms, Stanford/Packard study shows 4...ilZyme AP Conjugate Stabilizer is an aqueous solut...her non-toxic stabilizing chemicals in a MES buffe... This product contains a combination of 0.02% met...preservative. StabilZyme AP Conjugate Stabilizer ...
Mouse Anti-Myoglobin Monoclonal Antibody, Biotin Conjugated, Clone 4E2 from Meridian Life Science, Inc.
... nonspecific binding is a problem in your applicat...vidin products as superior alternatives to avidin ...derivative that combines several key features to p... low nonspecific binding properties. NeutrAvidin d...
BlueView Nucleic Acid Stain from Sigma-Aldrich
Biology Products: